Clinical Trial

Nurse-Led Self-Management Program on Taste Alteration in Women With Breast Cancer

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 26, 2026 (before its estimated July 19, 2026 completion). Its status may not reflect the trial's current state.
Summary
Taste alteration is a common and distressing symptom experienced by women with breast cancer receiving taxane-based chemotherapy. This symptom may negatively affect food intake, nutritional status, psychological well-being, and quality of life. Although several approaches have been suggested for the management of chemotherapy-related taste alteration, evidence regarding structured nurse-led self-management interventions in this patient group remains limited.
Trial Details
NCT Number NCT07670221
Lead Sponsor Izmir Bakircay University
Conditions Chemotherapy-Related Taste Alteration
Enrollment 68 participants
Start Date 2026-02-16
Primary Completion 2026-07-19 (estimated)
Study Completion 2026-08-24 (estimated)
Updated on ClinicalTrials.gov 2026-06-26